pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 11·1 min read
save

FDA policy lets some flavored vapes stay on shelves without full approval, raising expert concerns

May 11, 2026·read at STAT ↗RegulatoryNegative

The Food and Drug Administration announced a new guidance that allows certain flavored e-cigarettes and nicotine pouches to remain on the market even though they have not received full authorization.

Under the guidance, a product can stay available if the manufacturer has filed an application that the FDA has accepted and, for flavored vapes, has supplied data the agency considers sufficient to judge whether the product protects public health, weighing youth-use risk against any benefit.

Public health experts warned that the policy acts like a "get-out-of-jail-free card" for companies selling products illegally, and they expressed concern that the FDA’s large backlog of applications may delay proper review.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “No FDA permission, no problem: New flavored vape policy worries experts”

read at STAT ↗
720 words · retrieved May 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ASTELLASUltragenyx Pharmaceutical Inc.
drugs
nicotine3nicotine ER3Rare Disease
topics
DermatologyPsychiatry & CNSRare Disease

related stories

  • 10h agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Jul 28Anthony Fauci’s pandemic-era diary entriesSTAT
  • Jul 8Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsSTAT
  • Jul 1FDA says Zyn can market its pouches as safer than cigarettesSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive